Wells Fargo’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Sell
132,249
-26,939
-17% -$747K ﹤0.01% 2936
2025
Q4
$4.41M Buy
159,188
+41,865
+36% +$1.07M ﹤0.01% 2802
2025
Q3
$2.85M Buy
117,323
+33,912
+41% +$675K ﹤0.01% 3063
2025
Q2
$1.42M Sell
83,411
-53,462
-39% -$931K ﹤0.01% 3479
2025
Q1
$2.67M Buy
136,873
+8,871
+7% +$232K ﹤0.01% 2935
2024
Q4
$3.17M Buy
128,002
+19,158
+18% +$489K ﹤0.01% 2805
2024
Q3
$2.67M Buy
108,844
+47,091
+76% +$1.22M ﹤0.01% 2836
2024
Q2
$1.45M Buy
61,753
+14,880
+32% +$365K ﹤0.01% 3230
2024
Q1
$1.55M Buy
46,873
+9,927
+27% +$309K ﹤0.01% 3172
2023
Q4
$1.01M Sell
36,946
-61,174
-62% -$1.52M ﹤0.01% 3424
2023
Q3
$2.36M Buy
98,120
+12,471
+15% +$334K ﹤0.01% 2673
2023
Q2
$2.73M Buy
85,649
+26,076
+44% +$846K ﹤0.01% 2637
2023
Q1
$1.82M Buy
59,573
+43,014
+260% +$1.7M ﹤0.01% 2938
2022
Q4
$648K Sell
16,559
-4,448
-21% -$199K ﹤0.01% 3486
2022
Q3
$1M Sell
21,007
-54,017
-72% -$3.08M ﹤0.01% 3248
2022
Q2
$2.9M Sell
75,024
-14,505
-16% -$577K ﹤0.01% 2497
2022
Q1
$5.13M Buy
89,529
+23,406
+35% +$1.54M ﹤0.01% 2438
2021
Q4
$5.27M Buy
66,123
+11,336
+21% +$971K ﹤0.01% 2517
2021
Q3
$4.77M Sell
54,787
-3,483
-6% -$350K ﹤0.01% 2873
2021
Q2
$7.5M Buy
58,270
+12,636
+28% +$1.01M ﹤0.01% 2475
2021
Q1
$3.65M Buy
45,634
+7,432
+19% +$707K ﹤0.01% 3151
2020
Q4
$3.12M Buy
38,202
+5,151
+16% +$253K ﹤0.01% 3154
2020
Q3
$814K Buy
33,051
+18,508
+127% +$459K ﹤0.01% 4011
2020
Q2
$407K Buy
14,543
+6,640
+84% +$143K ﹤0.01% 4477
2020
Q1
$142K Buy
+7,903
New +$172K ﹤0.01% 4883

Other funds holding BEAM